Gilead Sciences Inc. share price logo

Gilead Sciences Inc. Share Price

NASDAQ: GILD

Large Cap

$113.01

+0.30

(+0.27%)

as on

Gilead Sciences Inc. Stock Performance

as on September 4, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $112.33
    $113.4
    downward going graph

    0.60%

    Downside

    0.35%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $77.74
    $121.83
    downward going graph

    31.21%

    Downside

    7.80%

    Upside

    downward going graph

Gilead Sciences Inc. share price movements today

Previous Close
$112.71
Open
$112.41
Volume
2.2M
Day's Low - High
$112.33 - $113.4
52 Week Low - High
$77.74 - $121.83

Gilead Sciences Inc. Historical Returns

1 Month Return
-0.19 %
3 Month Return
+ 3.33 %
1 Year Return
+ 41.74 %
3 Year Return
+ 77.01 %
5 Year Return
+ 71.4 %

Gilead Sciences Inc. Stock Fundamentals & Key Indicators

Check Gilead Sciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$139.9B

EPS (TTM)

8.0948

Dividend Yield

3.74%

Quarterly Earnings Growth YOY

0.21%

PE Ratio (TTM)

22.36

Industry PE ratio

11.18

P/B Ratio

22.3631

PEG Ratio

0.212

EBITDA

13.8B

Revenue (TTM)

28.9B

Profit Margin

21.87%

Return On Equity TTM

33.40%

Gilead Sciences Inc. Stock Valuation

Track how Gilead Sciences Inc. P/E has moved over time to understand its valuation trends.

Gilead Sciences Inc. in the last 5 years

  • Overview

  • Trends

Lowest (7.99x)

September 30, 2021

Industry (11.18x)

September 3, 2025

Today (22.36x)

September 3, 2025

Highest (19.53x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 22.36x

Gilead Sciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gilead Sciences Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
HOLD$139.9B71.4%22.3621.87%
BUY$659.1B391.6%48.0225.91%
BUY$374.4B129.02%100.916.45%
BUY$248.7B73.51%14.5135.61%
BUY$428.8B18.47%19.0425.00%

Stock Returns calculator for Gilead Sciences Inc. Stock including INR - Dollar returns

The Gilead Sciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gilead Sciences Inc. investment value today

Current value as on today

₹1,46,713

Returns

₹46,713

(+46.71%)

Returns from Gilead Sciences Inc. Stock

₹41,794 (+41.79%)

Dollar Returns*

₹4,919 (+4.92%)

Analyst Recommendation on Gilead Sciences Inc. Stock

Based on 38 analysts

HOLD

47.37%

Buy

52.63%

Hold

0.00%

Sell

Based on 38 analysts, 52.63% of analysts recommend a 'HOLD' rating for Gilead Sciences Inc.. Average target price of $124.37

Gilead Sciences Inc. Share Price Target

Get share price movements and forecasts by analysts on Gilead Sciences Inc..

What analysts predicted

9.13%UPSIDE

Target Price

$124.37

Current Price

$113.01

Analyzed by

38 Analysts

Target

$124.37

Gilead Sciences Inc. target price $124.37, a slight upside of 9.13% compared to current price of $113.01. According to 38 analysts rating.

Gilead Sciences Inc. Stock's Interest Amongst Investors

Investment in Gilead Sciences Inc. Shares on INDmoney has grown by 21.81% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:21.81% versus previous 30 day period

Search interest for Gilead Sciences Inc. Stock has increased by 35% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:35% versus previous 30 day period

Gilead Sciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
6,352
6,599
7,050
7,114
6,686
6,953
7,545
7,569
6,667
7,081
Gross Profit
4,951
5,157
5,485
5,024
5,134
5,409
5,971
5,988
5,127
5,580
Operating Income
1,705
1,665
2,623
1,612
-4,322
2,644
888
2,452
2,237
2,474
EBITDA
2,170
2,499
3,234
2,593
-3,542
2,984
1,884
3,109
2,605
3,374
Interest Expense
230
230
232
252
254
237
238
249
260
254
Depreciation
640
681
684
688
690
694
690
693
696
691
Income Before Tax
1,300
1,588
2,318
1,653
-4,486
2,053
956
2,167
1,649
2,429
Income Tax Expense
316
549
146
237
-315
438
-297
385
334
468
Net Income
1,010
1,045
2,180
1,429
-4,170
1,614
1,253
1,783
1,315
1,960
Net Profit Margin
15.90%
15.84%
30.92%
20.09%
-62.37%
23.21%
16.61%
23.56%
19.72%
27.68%

Gilead Sciences Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
32,639
30,390
26,107
22,127
22,449
24,689
27,305
27,281
27,116
28,754
Gross Profit
28,633
26,129
21,736
17,274
17,774
20,117
20,704
21,624
27,116
22,503
Operating Income
22,193
17,633
14,124
8,200
4,287
4,071
9,918
7,330
7,605
1,662
EBITDA
23,445
19,219
15,933
10,305
7,559
4,133
11,329
8,852
7,605
4,434
Interest Expense
688
964
1,118
1,077
995
984
1,001
935
944
977
Depreciation
-
-
1,286
1,429
1,404
1,480
2,050
2,103
2,533
2,767
Income Before Tax
21,659
17,097
13,529
7,799
5,160
1,669
8,278
5,814
6,859
690
Income Tax Expense
3,553
3,609
8,885
2,339
-204
1,580
2,077
1,248
-1,247
211
Net Income
18,108
13,501
4,628
5,455
5,386
123
6,225
4,592
5,665
480
Net Profit Margin
55.48%
44.43%
17.73%
24.65%
23.99%
0.50%
22.80%
16.83%
20.89%
1.67%

Gilead Sciences Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
1,039
2,172
1,417
-4,170
1,614
1,253
1,783
1,315
1,960
Operating Cash Flow
2,337
1,755
2,169
2,219
1,325
4,309
2,975
1,757
827
Investing Cash Flow
-483
-229
-727
-2,207
-307
-710
-225
-415
-2,116
Financing Cash Flow
-1,101
-1,519
-1,099
-1,361
-2,953
-1,379
2,260
-3,426
-1,567
Change in Cash
768
1
380
-1,367
-1,946
2,265
4,954
-2,065
-2,782

Gilead Sciences Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
13,488
4,644
5,460
5,364
89
6,201
4,566
5,665
480
Operating Cash Flow
17,047
11,898
8,400
9,144
8,168
11,384
9,072
8,006
10,828
Investing Cash Flow
-11,985
-16,069
14,355
-7,817
-14,615
-3,131
-2,466
-2,265
-3,449
Financing Cash Flow
-9,725
3,393
-12,318
-7,634
770
-8,877
-6,469
-5,125
-3,433
Change in Cash
-4,622
-641
10,352
-6,309
-5,634
-659
74
673
3,906

Mutual Funds that own Gilead Sciences Inc. Stock

Check out the Mutual Funds with significant holdings in Gilead Sciences Inc..

Global Institutional Holdings in Gilead Sciences Inc.

Funds
Holdings
Vanguard Group Inc
9.47%
BlackRock Inc
9.36%
State Street Corp
4.8%
FMR Inc
4.72%
Capital Research Global Investors
4.4%

Gilead Sciences Inc. News & Key Events

  • img

    Today's Timeline - 14 August

    Thu, 11:03 AM

    -

    Gilead Sciences reports strong Q2 earnings, beating revenue and EPS estimates, driven by HIV portfolio growth and new product launches.

Insights on Gilead Sciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Gilead Sciences Inc. has reported an increase in net profit for the last two quarters. The net profit rose from $1.31 billion to $1.96 billion, reflecting an average increase of 32.9% per quarter.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Gilead Sciences Inc. has shown a positive trend in its revenue over the last two quarters. Revenue increased from $6.66 billion to $7.08 billion, reflecting an average growth of 5.9% per quarter.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, GILD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GILD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, GILD stock has moved up by 41.4%

About Gilead Sciences Inc.

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
OrganisationGilead Sciences Inc.
Headquarters333 Lakeside Drive, Foster City, CA, United States, 94404
IndustryHealth Technology
CEOMr. Daniel P. O'Day
E-voting on sharesClick here to vote

Key Management of Gilead Sciences Inc.

Name

Title

Dr. Linda Slanec Higgins Ph.D.

Senior Vice President of Research, Innovation & Portfolio

Mr. Daniel P. O'Day

Chairman & CEO

Mr. Andrew D. Dickinson

Chief Financial Officer

Ms. Johanna Mercier

Chief Commercial Officer

Ms. Diane E. Wilfong

Interim Corporate Controller, Chief Accounting Officer & Principal Accounting Officer

Ms. Jyoti K. Mehra

Executive Vice President of Human Resources

Ms. Deborah H. Telman J.D.

Executive VP of Corporate Affairs, General Counsel & Corporate Secretary

Ms. Jacquie Ross C.F.A.

Senior Vice President of Treasury and Investor Relations

Dr. Flavius Martin M.D.

Executive Vice President of Research

Ms. Janet Dorling

Senior Vice President of Intercontinental Region & Global Patient Solutions

FAQs

What is Gilead Sciences Inc. share price today?

Gilead Sciences Inc. share price today is $113.01 as on at the close of the market. Gilead Sciences Inc. share today touched a day high of $113.4 and a low of $112.33.

What is the 52 week high and 52 week low for Gilead Sciences Inc. share?

Gilead Sciences Inc. share touched a 52 week high of $121.83 on and a 52 week low of $77.74 on . Gilead Sciences Inc. stock price today i.e. is closed at $113.01,which is 7.24% down from its 52 week high and 45.37% up from its 52 week low.

What is Gilead Sciences Inc.'s market capitalisation today?

Gilead Sciences Inc. market capitalisation is $0.14T as on .

How to invest in Gilead Sciences Inc. Stock (GILD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gilead Sciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gilead Sciences Inc. Shares that will get you 0.0133 shares as per Gilead Sciences Inc. share price of $113.01 per share as on September 4, 2025 at 1:29 am IST.

What is the minimum amount required to buy Gilead Sciences Inc. Stock (GILD) from India?

Indian investors can start investing in Gilead Sciences Inc. (GILD) shares with as little as ₹88.035 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.35 in Gilead Sciences Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Gilead Sciences Inc. share’s latest price of $113.01 as on September 4, 2025 at 1:29 am IST, you will get 0.0885 shares of Gilead Sciences Inc.. Learn more about fractional shares .

What are the returns that Gilead Sciences Inc. has given to Indian investors in the last 5 years?

Gilead Sciences Inc. stock has given 71.4% share price returns and 20.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?